SCHEMBL6892495

SCHEMBL6892495

NC(=O)c1ccc(C(N)=O)[n+]([O-])c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 3/20 0.45
CA1 P00915 2/20 0.41
NNMT P40261 2/20 0.41
CA12 O43570 1/20 0.41
CA9 Q16790 1/20 0.41
CA14 Q9ULX7 1/20 0.41
ACHE P22303 2/20 0.41
TSHR P16473 2/20 0.39
PARP10 Q53GL7 6/20 0.39
PARP4 Q9UKK3 2/20 0.39
PARP15 Q460N3 2/20 0.39
ALDH1A1 P00352 1/20 0.39
KMT2A Q03164 1/20 0.39
PARP14 Q460N5 1/20 0.39
PARP16 Q8N5Y8 1/20 0.39
PARP11 Q9NR21 1/20 0.39
PARP1 P09874 2/20 0.38
POLB P06746 1/20 0.38
CYP3A4 P08684 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11545665 0.79 CA2 (0.45) CA2CA1NNMTCA12CA9
Potassium Ion SCHEMBL30884945 0.76 CA2 (0.42) CA2CA1NNMTCA12CA9
SCHEMBL3646701 0.72 KMT2A (0.48) CA2CA1CA12CA9CA14
Bromide SCHEMBL7178411 0.69 PARP10 (0.41) CA2CA1NNMTACHEPARP10
SCHEMBL2833136 0.68 KDM4E (0.43) NNMTTSHRALDH1A1KMT2APARP1
SCHEMBL30488814 0.68 KDM4E (0.43) NNMTTSHRALDH1A1KMT2APARP1
Terephthalamide SCHEMBL23774 0.68 PARP1 (0.71) CA2CA1NNMTCA12CA9
SCHEMBL1615851 0.67 CA1 (0.47) CA2CA1CA12CA9CA14
SCHEMBL29618255 0.67 MEN1 (0.68) NNMTTSHRKMT2APARP1POLB
SCHEMBL128526 0.67 MEN1 (0.68) NNMTTSHRKMT2APARP1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2004502669-A 2004-01-29 JP claimed
EP-1353898-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2003-10-22 EP claimed
WO-2002002512-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-01-10 WO claimed